Effect of Alendronate on Healing of Bone Defect and Gingival Tissue in Osteopenic Rats

The aim was to evaluate bone repair and gingival tissue repair in osteopenic rats. Fifteen female wistar rats were included; in all of them ovariectomy was realized to induce osteopenia; after 45 days, the animals were submitted to 2 surgical techinques 1) dental extraction of the upper central incisor with no socket preservation and 2) 5 mm cranial defect in the calvarium; 5 ra ts were included in the control group (G1) withput alendronate application; in the group 2 (G2) was used subcutenous alendronate (0.5 m g/kg) once for three weeks and then was realizd the both surgical techniques. In group 3 (G3), after ovariectomy was realized the bot h dental extraction and the calvarium defect and after that was realized the alendronate protocol. In each group, after six week was rea lized euthanasia and descriptive histological analysis of the surgical areas involved. In bone formation of the 5 mm cranial defect w as observed with good progression in the 3 experimental models and no modification in quality of bone repair was observed. For the gingival tissue in the extraction socket, no differences were observed between G1 and G3. On other hand, in G2 a thinner and reduced gingival e pithelium was found. Our results showed that alendronate was not an obstacle for bone repair; deficiencies in re-epithelialization of ora l muc sa show the impact of alendronate before dental extraction.

[1]  R. Okamoto,et al.  Short term sodium alendronate administration improves the peri-implant bone quality in osteoporotic animals , 2017, Journal of applied oral science : revista FOB.

[2]  Makoto Shiozaki,et al.  Risedronate improves bone architecture and strength faster than alendronate in ovariectomized rats on a low-calcium diet , 2014, Journal of Bone and Mineral Metabolism.

[3]  J. Cotelingam,et al.  Bisphosphonate-related osteonecrosis of the jaw. , 2014, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

[4]  G. Thomas,et al.  In vitro effect of bisphosphonates on oral keratinocytes and fibroblasts. , 2014, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[5]  M. Lopes,et al.  Alendronate-associated osteonecrosis of the jaws: A review of the main topics , 2013, Medicina oral, patologia oral y cirugia bucal.

[6]  Vijay Kumar,et al.  Evolution and Etiopathogenesis of Bisphosphonates Induced Osteonecrosis of the Jaw , 2013, North American journal of medical sciences.

[7]  M. Mozzati,et al.  Tooth extraction in osteoporotic patients taking oral bisphosphonates , 2013, Osteoporosis International.

[8]  Yueying Liu,et al.  Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts. , 2011, Archives of oral biology.

[9]  Arun K Gosain,et al.  Testing the Critical Size in Calvarial Bone Defects: Revisiting the Concept of a Critical-Size Defect , 2010, Plastic and reconstructive surgery.

[10]  G. Watzek,et al.  Is Zoledronate Toxic to Human Periodontal Fibroblasts? , 2010, Journal of dental research.

[11]  C. Chin,et al.  Femur bone repair in ovariectomized rats under the local action of alendronate, hydroxyapatite and the association of alendronate and hydroxyapatite , 2009, International journal of experimental pathology.

[12]  K. Takeuchi,et al.  Antral ulcers induced by alendronate, a nitrogen-containing biphophonate, in rat stomachs - prophylactic effect of rebamipide. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[13]  P. Papapetrou Bisphosphonate-associated adverse events , 2009, Hormones.

[14]  K. Cullen,et al.  Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate‐associated osteonecrosis , 2009, British journal of haematology.

[15]  S. Cremers,et al.  Inhibition of oral mucosal cell wound healing by bisphosphonates. , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[16]  I. Reid,et al.  Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? , 2007, Bone.

[17]  I. Dimitrakopoulos,et al.  Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases. , 2006, International journal of oral and maxillofacial surgery.

[18]  D. Peterson,et al.  Bisphosphonate‐associated osteonecrosis of mandibular and maxillary bone , 2005, Cancer.

[19]  J. Lane,et al.  Osteoporosis: a review. , 2004, Clinical orthopaedics and related research.

[20]  T. Wronski,et al.  Time course of femoral neck osteopenia in ovariectomized rats. , 1996, Bone.

[21]  T. Dodson,et al.  Medication-Related Osteonecrosis of the Jaw—2014 Update , 2014 .

[22]  S. Woo,et al.  Biophosphonate-related osteonecrosis of the jaws. , 2008, Dental clinics of North America.